Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST
Clinical trial NCT04148092 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04148092
- Sponsor
- Deciphera Pharmaceuticals, LLC
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.